Biomarkers in Cancer Detection and Monitoring of Therapeutics : Volume 2: Diagnostic and Therapeutic Applications

著者名：Sobti PhD, Ranbir Chander (EDT)/Watanabe, Masatoshi (EDT)/Sobti, Aastha (EDT)

Academic Press（2023/11/16発売）

• 言語：ENG
• ISBN：9780323951142
• eISBN：9780323951159

Description

Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case. This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.- Provides up-to-date information on current molecular biomarkers research for cancer- Presents new diagnostic techniques using biomarkers that can leverage quicker results that can be essential for patient's survivorship- Discusses several novel therapeutics applied to specific cancer types, such as head and neck, oral, GI tract, breast, lung and hepatocellular carcinomas

Table of Contents

1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVEHimani Sharma2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENTShyam Aggarwal3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINKShamsher Singh4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMAGowtham Kumar Subbaraj5. ORAL SQUAMOUS CELL CARCINOMAAnubha Gulati6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMARamakrishnan Veerabathiran7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIASaurabh Yadav8. MYELODYSPLASTIC SYNDROME – A CHALLENGING ENTITYAnshu Palta9. MULTIPLE MYELOMAVijay Goni10. MOLECULAR BIOMARKERS IN PROSTATE CANCERKATSUNORI UCHIDA and Remi Semba11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERSAnshika Srivastava12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCERKanagaraj Palaniyandi13. MOLECULAR BIOMARKERS IN GASTRIC CANCERYoshifumi S. Hirokawa and Kazuki Kanayama14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMAYoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCERAashima Arora16. BIOMARKERS IN ENDOCRINE DISEASESSunil Chumber and Dhritiman Maitra17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONSKousik Pramanick18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTSNithar Ranjan Madhu Sr.19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCEMaushmi Shailesh Kumar20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPYOlorunfemi Raphael Molehin21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENTMaushami Kumar and Maushmi Shailesh Kumar22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCHPunarbasu Choawdhury23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESISAnandan Balakrishnan24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVESuman Adhikari25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMALAnimesh Pan26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENTCarolina Panis